1. Inhalt
  2. Navigation
  3. Weitere Inhalte
  4. Metanavigation
  5. Suche
  6. Choose from 30 Languages

Business

Deal To Sell Bayer Division Collapses

German chemical and pharmaceutical giant Bayer said Thursday it had cancelled the planned sale of its Rhein Chemie division to U.S.-based Advent International. In October, the two companies reached an agreement for the sale of the company in a deal worth approximately €215 million ($216.5 million). The companies were unable to agree to the final terms of the deal. Bayer had planned to shed Rhein Chemie as part of efforts to reduce its overall debt to a level below €10 billion. A company spokesman said the company is still on track to meeting that goal by year's end and that it will review its strategic options for Rhein Chemie.